FDA wants closer scrutiny of new diabetes drugs

With type 2 diabetes already increasing heart risks, the FDA is seeking assurances that new drugs won't do further damage.
Posted in Health Insurance, Healthcare, Medicare |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.